Centinel Spine Announces IDE Approval of Two Different prodisc® C Devices
New York, NY, July 18, 2019 – Centinel Spine®, LLC, the largest privately-held spine company focused on anterior column reconstruction, today announced that it received Investigational Device Exemption (IDE) approval … Continue Reading Centinel Spine Announces IDE Approval of Two Different prodisc® C Devices